OTC labeling
This article was originally published in The Rose Sheet
Executive Summary
Agenda for OTC labeling working group meeting Sept. 17 includes discussions on columns, alternative packaging and the exemption process. The meeting will be the fourth in a series of at least five meetings to be held between FDA and industry on the final rule (1"The Rose Sheet" Aug. 23, p. 5). The topic of the Aug. 24 meeting was the effect of the reg on product trade dress (2see related stories, pp. 3-5). An agenda for a working group scheduled for Nov. 1 has not yet been set
You may also be interested in...
OTC Labeling Exemption Requests For Ophthalmics Denied By FDA
Two requests for exemptions from certain provisions of the OTC labeling final rule are denied by FDA in Aug. 23 letters. Zee Medical and Automatic Liquid Packaging sought relief from the reg's 6-point type size requirement for their respective OTC ophthalmic products.
OTC Labeling Exemption Requests For Ophthalmics Denied By FDA
Two requests for exemptions from certain provisions of the OTC labeling final rule are denied by FDA in Aug. 23 letters. Zee Medical and Automatic Liquid Packaging sought relief from the reg's 6-point type size requirement for their respective OTC ophthalmic products.
Trade Dress Exemption Could Be Short-Term Fix To OTC Label Issues - CTFA
A general exemption for OTC products that meet a "clear and conspicuous" performance standard may be an "intermediate fix" for those that do not meet the color requirements in the OTC labeling rule, Cosmetic, Toiletry and Fragrance Association VP-Legal & General Counsel Thomas Donegan said. He spoke at an FDA working group meeting to discuss product labeling in Rockville, Md. Aug. 24.